Opus Genetics (IRD) Share-based Compensation (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.98% |
| Dec 31, 2025 | -409.44% |
| Sep 30, 2025 | -8.93% |
| Jun 30, 2025 | -1.86% |
| Mar 31, 2025 | -71.13% |
| Jun 30, 2024 | 228.98% |
| Mar 31, 2024 | -65.54% |
| Dec 31, 2023 | 24.08% |
| Sep 30, 2023 | -59.70% |
| Jun 30, 2023 | -99.42% |
| Mar 31, 2023 | 20,197.64% |
| Dec 31, 2022 | -1,341.41% |
| Sep 30, 2022 | -77.75% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -7.10% |
| Dec 31, 2021 | 1,742.31% |
| Sep 30, 2021 | -10.34% |
| Jun 30, 2021 | -94.13% |
| Mar 31, 2021 | -3.70% |
| Dec 31, 2020 | -16.72% |
| Sep 30, 2020 | 94.94% |
| Jun 30, 2020 | 418.03% |
| Mar 31, 2020 | 185.50% |
| Dec 31, 2019 | -178.67% |
| Sep 30, 2019 | -28.95% |
| Jun 30, 2019 | -20.71% |
| Mar 31, 2019 | 119.57% |
| Dec 31, 2018 | -392.22% |
| Sep 30, 2018 | 5.36% |
| Jun 30, 2018 | -9.92% |
| Mar 31, 2018 | 16.69% |
| Dec 31, 2017 | 11.66% |
| Sep 30, 2017 | -20.99% |
| Jun 30, 2017 | 5.01% |
| Mar 31, 2017 | -79.09% |
| Dec 31, 2016 | 255.13% |
| Sep 30, 2016 | 5.19% |
| Jun 30, 2016 | 2.38% |
| Mar 31, 2016 | -63.34% |
| Dec 31, 2015 | 315.27% |
| Sep 30, 2015 | -17.15% |
| Jun 30, 2015 | 383.50% |
| Mar 31, 2015 | -69.55% |
| Dec 31, 2014 | 13.20% |
| Sep 30, 2014 | 23.15% |
| Jun 30, 2014 | 3.25% |
| Mar 31, 2014 | 79.78% |
| Dec 31, 2013 | 5.43% |
| Sep 30, 2013 | 24.54% |
| Jun 30, 2013 | -85.38% |
| Mar 31, 2013 | 1,207.38% |
| Dec 31, 2012 | -53.06% |
| Sep 30, 2012 | 19.43% |
| Jun 30, 2012 | -44.34% |
| Mar 31, 2012 | -27.27% |
| Dec 31, 2011 | -11.15% |
| Sep 30, 2011 | -17.09% |
| Jun 30, 2011 | -15.75% |
| Mar 31, 2011 | 118.71% |
| Dec 31, 2010 | -180.53% |